Search Results - "Cheon, Jaekyung"

Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab by Bang, Kyunghye, Cheon, Jaekyung, Park, Young Soo, Kim, Hyung-Don, Ryu, Min-Hee, Park, Yangsoon, Moon, Meesun, Lee, Hyungeun, Kang, Yoon-Koo

“…Background The GASTHER1 study showed that re-evaluation of HER2 status rescued 8% of HER2-positive gastric cancer (GC) patients with initially HER2-negative…”
Get full text

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study by Kim, Beom Kyung, Cheon, Jaekyung, Kim, Hyeyeong, Kang, Beodeul, Ha, Yeonjung, Kim, Do Young, Hwang, Seong Gyu, Chon, Young Eun, Chon, Hong Jae

“…Lenvatinib (LENV) and atezolizumab/bevacizumab (ATE/BEV) have been approved as first-line regimens for the treatment of unresectable hepatocellular carcinoma…”
Get full text

Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation by Cheon, Jaekyung, Lee, Yoo Jin, Jo, Jae-Cheol, Kweon, Kukju, Koh, SuJin, Min, Young Ju, Park, Sang-Hyuk, Lee, Sin-hye, Kim, Hyo-jin, Choi, Yunsuk

“…Purpose The survival rates of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) have improved. However, HSCT can induce significant…”
Get full text

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer by Lee, Seung Joon, Yang, Hannah, Kim, Woo Ram, Lee, Yu Seong, Lee, Won Suk, Kong, So Jung, Lee, Hye Jin, Kim, Jeong Hun, Cheon, Jaekyung, Kang, Beodeul, Chon, Hong Jae, Kim, Chan

“…BackgroundPeritoneal carcinomatosis is a fatal clinical presentation of colon cancer, characterized by unresponsiveness to conventional anticancer therapies,…”
Get full text

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma by Cheon, Jaekyung, Kim, Hyeyeong, Kim, Han Sang, Kim, Chang Gon, Kim, Ilhwan, Kang, Beodeul, Kim, Chan, Jung, Sanghoon, Ha, Yeonjung, Chon, Hong Jae

“…Background: Atezolizumab plus bevacizumab (Ate/Bev) demonstrated promising efficacy and safety in patients with advanced hepatocellular carcinoma (HCC) in the…”
Get full text

The c-Abl inhibitor, radotinib induces apoptosis in multiple myeloma cells via mitochondrial-dependent pathway by Heo, Sook-Kyoung, Noh, Eui-Kyu, Kim, Jeong Yi, Yu, Ho-Min, Sung, Jun Young, Ju, Lan Jeong, Kim, Do Kyoung, Seo, Hye Jin, Lee, Yoo Jin, Cheon, Jaekyung, Koh, SuJin, Min, Young Joo, Choi, Yunsuk, Jo, Jae-Cheol

“…Multiple myeloma (MM) is a hematological cancer resulting from accumulated abnormal plasma cells. Unfortunately, MM remains an incurable disease, as relapse is…”
Get full text

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment by Chon, Young Eun, Cheon, Jaekyung, Kim, Hyeyeong, Kang, Beodeul, Ha, Yeonjung, Kim, Do young, Hwang, Seong Gyu, Chon, Hong Jae, Kim, Beom Kyung

“…Background Since atezolizumab plus bevacizumab (ATE+BEV) regimen for patients with unresectable hepatocellular carcinoma (HCC) was released quite recently,…”
Get full text

Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patients by Kim, Hyeyeong, Cheon, Jaekyung, Ha, Yeongjung, Kim, Han Sang, Kim, Chang Gon, Kim, Ilhwan, Kim, Chan, Jung, Sang-hoon, Chon, Hong Jae

“…Abstract only 397 Background: Atezolizumab plus bevacizumab (Ate/Bev) demonstrated promising efficacy and safety in patients with advanced hepatocellular…”
Get full text

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy by Bang, Kyunghye, Cheon, Jaekyung, Jeong, Jae Ho, Im, Hyeon-Su, Kim, Kyu-pyo, Ryoo, Baek-Yeol, Yoo, Changhoon

“…Introduction: Liposomal irinotecan (nal-IRI) plus fluorouracil/leucovorin (5-FU/LV) has shown clinical benefit in patients with metastatic pancreatic…”
Get full text

Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events by Yoo, Changhoon, Byeon, Seonggyu, Bang, Yeonghak, Cheon, Jaekyung, Kim, Jin W., Kim, Jee H., Chon, Hong J., Kang, Beodeul, Kang, Myoung J., Kim, Ilhwan, Hwang, Jun‐Eul, Kang, Jung H., Lee, Myung A., Hong, Jung Y., Lim, Ho Y., Ryoo, Baek‐Yeol

“…Background & Aims Regorafenib demonstrated a clinical benefit for patients with unresectable hepatocellular carcinoma (uHCC) in the phase III RESORCE trial…”
Get full text

The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma by Kim, Han Sang, Kim, Chang Gon, Hong, Jung Yong, Kim, Il-hwan, Kang, Beodeul, Jung, Sanghoon, Kim, Chan, Shin, Sang Joon, Choi, Hye Jin, Cheon, Jaekyung, Chon, Hong Jae, Lim, Ho Yeong

“…Purpose: Inter-tumoral heterogeneity at the differential lesion level raises the possibility of distinct organ-specific responses to immune checkpoint…”
Get full text

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma by Yang, Hannah, Kang, Beodeul, Ha, Yeonjung, Lee, Sung Hwan, Kim, Ilhwan, Kim, Hyeyeong, Lee, Won Suk, Kim, Gwangil, Jung, Sanghoon, Rha, Sun Young, Gaillard, Vincent E., Cheon, Jaekyung, Kim, Chan, Chon, Hong Jae

“…We elucidated the clinical and immunologic implications of serum IL-6 levels in patients with unresectable hepatocellular carcinoma (HCC) treated with…”
Get full text

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis by Cheon, Jaekyung, Lee, Choong-kun, Sang, Yun Beom, Choi, Hye Jin, Kim, Min Hwan, Ji, Jun Ho, Ko, Kwang Hyun, Kwon, Chang-Il, Kim, Dae Jung, Choi, Sung Hoon, Kim, Chan, Kang, Beodeul, Chon, Hong Jae

“…Background: A recent phase II trial reported prolonged survival in patients with advanced biliary tract cancer (BTC) following treatment with nab-paclitaxel…”
Get full text

Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea by Cheon, Jaekyung, Im, Hyeon-Su, Shin, Ho-Jin, Kim, Inho, Lee, Won Sik, Lee, Kyung-Hun, Park, Seong Kyu, Kim, Min Kyoung, Choi, Un Jong, Kim, Jung Han, Lee, IlKyun, Jo, Jae-Cheol

“…Purpose This observational study aimed to evaluate the safety and efficacy of pegteograstim prophylaxis in patients with lymphoma and solid malignancies…”
Get full text

LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells by Heo, Sook-Kyoung, Choi, Yunsuk, Jeong, Yoo Kyung, Ju, Lan Jeong, Yu, Ho-Min, Kim, Do Kyoung, Seo, Hye Jin, Lee, Yoo Jin, Cheon, Jaekyung, Koh, SuJin, Min, Young Joo, Noh, Eui-Kyu, Jo, Jae-Cheol

“…Osteoporosis is a progressive systemic skeletal disease associated with decreased bone mineral density and deterioration of bone quality, and it affects…”
Get full text

Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis by Cheon, Jaekyung, Chon, Hong Jae, Bang, Yeonghak, Park, Neung Hwa, Shin, Jung Woo, Kim, Kang Mo, Lee, Han Chu, Lee, Jooho, Yoo, Changhoon, Ryoo, Baek-Yeol

“…Introduction/Objective: Lenvatinib demonstrated efficacy and safety in patients with advanced hepatocellular carcinoma (HCC) in the randomized phase III…”
Get full text

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death by Heo, Sook-Kyoung, Noh, Eui-Kyu, Yu, Ho-Min, Kim, Do Kyoung, Seo, Hye Jin, Lee, Yoo Jin, Cheon, Jaekyung, Koh, Su Jin, Min, Young Joo, Choi, Yunsuk, Jo, Jae-Cheol

“…Acute myeloid leukemia (AML) is a heterogeneous disease that frequently relapses after standard chemotherapy. Therefore, there is a need for the development of…”
Get full text

High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer by Park, Hyung Soon, Kim, Yoo Min, Kim, Sewha, Lee, Won Suk, Kong, So Jung, Yang, Hannah, Kang, Beodeul, Cheon, Jaekyung, Shin, Su-Jin, Kim, Chan, Chon, Hong Jae

“…BackgroundHigh endothelial venule (HEV) is a specialized vasculature for lymphocyte trafficking. While HEVs are frequently observed within gastric cancer (GC),…”
Get full text

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis by Chae, Heejung, Jeong, Hyehyun, Cheon, Jaekyung, Chon, Hong Jae, Ryu, Hyewon, Kim, Il-Hwan, Kang, Myoung Joo, Jeong, Jae Ho, Ryoo, Baek-Yeol, Kim, Kyu-pyo, Yoo, Changhoon

“…Background: FOLFIRINOX (fluorouracil, folinic acid, irinotecan plus oxaliplatin) is an effective standard first-line treatment option for advanced pancreatic…”
Get full text

CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia by Heo, Sook-Kyoung, Noh, Eui-Kyu, Ju, Lan Jeong, Sung, Jun Young, Jeong, Yoo Kyung, Cheon, Jaekyung, Koh, Su Jin, Min, Young Joo, Choi, Yunsuk, Jo, Jae-Cheol

“…Abstract Background Leukemia stem cells (LSCs) in play an important role in the initiation, relapse, and progression of acute myeloid leukemia (AML), and in…”
Get full text